Journal of the Saudi Heart Association
Volume 32

Issue 1

Article 11

2020

Systemic immune-inflammation index predicts mortality in
infective endocarditis

Follow this and additional works at: https://www.j-saudi-heart.com/jsha
Part of the Cardiology Commons

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative
Works 4.0 License.
Recommended Citation
Agus, Hicaz Z.; Kahraman, Serkan; Arslan, Cagdas; Yildirim, Ceren; Erturk, Mehmet; Kalkan, Ali K.; and
Yildiz, Mustafa (2020) "Systemic immune-inflammation index predicts mortality in infective endocarditis,"
Journal of the Saudi Heart Association: Vol. 32 : Iss. 1 , Article 11.
Available at: https://doi.org/10.37616/2212-5043.1010

This Original Article is brought to you for free and open access by Journal of the Saudi Heart Association. It has
been accepted for inclusion in Journal of the Saudi Heart Association by an authorized editor of Journal of the
Saudi Heart Association.

Hicaz Zencirkiran Agus*, Serkan Kahraman, Cagdas Arslan, Ceren Yildirim,
Mehmet Erturk, Ali Kemal Kalkan, Mustafa Yildiz
University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Training and Research Hospital,
Department of Cardiology, Istanbul, Turkey

Abstract
Objectives: The aim of our study was to evaluate the usefulness of systemic immune-inﬂammation index (SII) at
admission in predicting in-hospital mortality in patients with infective endocarditis.
Methods: 133 deﬁnite IE patients (≥18 years) according to modiﬁed Duke criteria, treated in our tertiary care hospital
between December 2009 and May 2019, were retrospectively analysed. Symptoms, comorbidities, predisposing valvular
diseases, prosthetic valve, device, history of injectable drug use, blood culture results, echocardiography ﬁndings, and
complications were collected. We calculated the SII as follows: SII ¼ platelet count £ neutrophil count/lymphocyte count
at admission.
Results: The median age of the patients was 56 (40e66) years. Prosthetic valve disease was the most frequent predisposing valve lesion. Staphylococcus species were the most common microorganisms. The most frequent complication
was in-hospital mortality (22%) followed by renal failure. Older population, syncope, increased inﬂammatory markers,
high systolic pulmonary artery pressure (PAPs), heart failure, renal failure, and septic shock were associated with high
mortality. However age, syncope, hypocalcemia, not going to surgery, and SII were independent predictors of in-hospital
mortality. According to receiver operating characteristic curve analysis, the optimal SII cut-off value for predicting
mortality was 2314 (area under the curve 0.641; P ¼ 0.019).
Conclusion: We demonstrated that high SII levels are independently associated with in-hospital mortality. The SII may
be a promising prognostic predictor for patients with infective endocarditis.
Keywords: Infective endocarditis, Mortality, Systemic immune-inﬂammation index, Clinical characteristics, Inﬂammatory markers

1. Introduction

I

nfective endocarditis (IE) is deﬁned as an
infection of a native or prosthetic cardiac valve,
endocardial surface, or cardiac device [1,2].
Despite the improvements in the diagnosis and
treatment of IE, mortality and morbidity remain
high [3,4]. The aim of the present study was to

evaluate the usefulness of the systemic immuneinﬂammation index (SII) at admission in predicting in-hospital mortality in patients with IE. The
increase of prosthetic valves or intracardiac devices, elderly patients with coexisting medical
conditions, [4e6] has changed the spectrum of IE.
Although rheumatic heart disease (RHD) still remains the key risk factor for IE in low-income
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countries, it has declined sharply and degenerative valvular lesions have become the most
frequent valvular abnormalities in developed
countries. Years ago, streptococci were the main
causative microorganisms of IE. However, recent
studies have shown a signiﬁcant increase in frequency of Staphylococcus aureus. So new
consensus guidelines have modiﬁed the approach
to antibiotic therapy and prophylaxis [7,8].
Risk stratiﬁcation in IE may help us to determine
timing of surgery, prevention of complications and
mortality that need more aggressive treatment. For
this purpose, several biomarkers such as the
neutrophilelymphocyte ratio (NLR) and platelet
lymphocyte ratio (PLR), have been evaluated for
several types of disease. Recently, an indicator that
is known as SII, that integrates three types of inﬂammatory cells (SII ¼ platelet count  neutrophil
count/lymphocyte count), has been shown to be
promising [9,10]. SII, which is positively correlated
with neutrophil, platelet counts and inversely
correlated with lymphocyte count, was ﬁrst developed by Hu et al. in 2014 [11]. Later, several studies
also evaluated its prognostic values in various tumors, such as renal cell cancer, lung cancer, prostate
cancer and in vasculitis [12e14]. Thus, the aim of
our study was to evaluate the role of SII at admission in predicting in-hospital mortality and characterize the factors that trigger unfavorable outcomes
in IE.

2. Materials and methods
133 deﬁnite IE patients (18 years) according to
modiﬁed Duke criteria, treated in our tertiary care
hospital between December 2009 and May 2019,
were retrospectively analysed. The local ethics
committee approved the study protocol. Patients
with inﬂammatory diseases, autoimmune disease
involving systemic lupus erythematosus, cancer,
leukemia or any other blood system diseases were
excluded. Retrospective evaluation of the patients
was performed using electronic medical records.
We excluded cancer and other blood system diseases by evaluating patients’ history, blood test results on admission and electronic medical records.
Symptoms, comorbidities including diabetes, hypertension, congestive heart failure, chronic kidney
disease, predisposing valvular diseases, prosthetic
valve, device, history of injectable drug use, blood
culture results, echocardiography ﬁndings, and
complications were collected.
Blood was collected from at least 3 separate
venous sites for blood cultures in all participants at
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Abbreviations
CHD
CRP
IE
MSCNS

congenital heart disease
C-reactive protein
infective endocarditis
Methicillin sensitive coagulase negative
staphylococci
MRCNS Methicillin resistant coagulase negative
staphylococci
NLR
neutrophilelymphocyte ratio
PAPs
systolic pulmonary artery pressure
PLR
platelet lymphocyte ratio
RHD
rheumatic heart disease
SII
systemic immune-inﬂammation index
TTE
transthorasic echocardiography
TEE
transoesaphageal echocardiography

1-hour intervals starting at admission to the hospital. Extra samples were drawn to examine various
speciﬁc antibodies. Any valves and structures
extracted during surgery were examined and sent
for culture. Based on either the American Heart
Association guidelines or the European Society of
Cardiology guidelines, empiric antibiotic treatment
was given [7,8]. According to blood culture results,
patients were switched over to suitable antibiotics.
All hematologic and biochemical data were obtained. Routine laboratory investigations such as
complete blood count, C-reactive protein (CRP)
level and serum chemistry were periodically recorded. Renal failure was identiﬁed if creatinine
increased > 0,5 mg/dL or 25% by using the most
common deﬁnition [15]. We calculated the SII as
follows: SII ¼ platelet count  neutrophil count/
lymphocyte count at admission. PLR and NLR were
directly calculated from complete blood count
results.
Each participant underwent an echocardiographic
examination by Vivid 5 (GE, Horten, Norway) or Epic
7 (Philips). The echocardiograms were analysed form
the records by an experienced cardiologist blinded to
the participants’ results. Nearly all patients underwent transesophageal echocardiography (TEE) to
determine suspected prosthetic valve endocarditis,
cardiac mechanical complications, or high clinical
suspicion of IE despite normal transthoracic echocardiographic ﬁndings. Measurements of the vegetation length were performed in various planes, and
the maximum length was selected. Other than sinus
rhythm were also found from the records.
The main indications for surgery were severe
heart failure, prevention of peripheral embolism
and uncontrolled infection. Outcomes were deﬁned
as in-hospital mortality, within 3 months mortality,
renal failure, rhythm disturbances, cerebrovascular

attack, transient ischemic attack, heart failure and
septic shock.
2.1. Statistical analysis
Statistical analysis was made using the computer
software Statistical Package for Social Sciences (IBM
SPSS Statistics for Windows, version 21.0. released
2012, IBM Corp., Armonk, New York, USA). Fitness
to normal distribution was analyzed with the Kolmogorov Simirnov test. Data was expressed as
“mean ± standard deviation (SD)” for normal distribution, “median (25th-75th percentiles)” for
abnormal distribution and “n (%)” for categorical
variables. The effects of different variables on clinical outcomes were calculated by univariate analysis
for each. The variables for which the unadjusted P
value was <0.05 in univariate regression analysis
were identiﬁed as potential risk markers and
included in the multivariate regression model. A pvalue <0.05 was considered statistically signiﬁcant.
Chi-square or Fischer exact tests were used to
analyze categorical variables. Mann-Whitney U test
was used for comparing quantitative variables with
abnormal distribution while Student t-test was used
for comparing the means between two groups with
normal distribution. ROC analysis was conducted to
determine the optimal SII value to indicate mortality
in terms of both sensitivity and speciﬁcity.

3. Results
A total of 133 patients with diagnosis of deﬁnite IE
were retrospectively assessed for ten years period.
Demographic, clinical ﬁndings, echocardiographic
and microbiological data are shown in Table 1.
Ninety one (68,4%) males and 42 (31.6%) females
were in this study, with the median age of 56
(40e66) years. The most common symptoms were
high fever (61.7%), dyspnea (55.6%) and weakness
(41.4%). Thirty one patients had a history of hypertension while ﬁve patients had a history of
injectable drug usage. Three patients were on dialysis and 9 patients had pacemaker. Fifteen patients’
rhythm was atrial ﬁbrillation during hospitalization.
Total median length of hospitalization was 35
(20,5e47) days.
Affected sites were mitral valve in 72 (54.1%),
aortic valve in 56 (42.1%), tricuspid valve in 6 (4,5%)
and intracardiac device in 7 (5.3%) patients. In our
study vegetation size was 10,4 ± 5,06 mm for aortic
valve, 9 (6e13) mm for mitral valve. Prosthetic
valve disease was the most frequent predisposing
valve lesion followed by degenerative valvular
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diseases, RHDs, mitral valve prolapse and bicuspid
aorta. The predominantly complications were
perforation in 23 (17,3%) and abscess in 16 (12,0%)
patients.
Staphylococcus species were the most common
microorganisms. Of these, coagulase-negative
staphylococci were the most common causative
pathogen (23,3%). The following microorganisms
were also isolated: Staphylococcus aureus (9,8%),
Streptococcus (8,3%), Enterococcus faecalis (5,3%). The
culture negative rate was 50,4%. This numerically
high culture negative rate can be explained by high
rate of antimicrobial usage in another hospital
prior to referral and inability to access archive
results.
Surgical therapy was performed in 96 patients
(72.2%). The median time interval from hospitalization to surgery was 17 (9,2e30) days. The most
frequent complication was in-hospital mortality
(22%). Acute renal failure occurred in 12% and heart
failure in 6% patients as a complication. Patients
were divided into 2 groups according to the presence of mortality (Table 1). In-hospital mortality
occurred in 30 patients. Several factors were associated with in-hospital mortality, including older
population, syncope, increased inﬂammatory
markers, high systolic pulmonary artery pressure
(PAPs), heart failure, renal failure, and septic shock.
In our study, the median value of SII was 1103
(679e1865), while 1063 (639e1620) in mortal group
and 1471 (841e2576) in survivors. SII and CRP
values were not different in terms of native and
prosthetic valve and also valve type. On univariate
logistic regression analysis, age, syncope, hypocalcemia, septic shock, renal failure, heart failure, high
WBC, neutrophil, monocyte, CRP, urea, creatinine,
PAPs, NLR, and SII were associated with high
mortality. Whereas, having surgery due to IE was
associated with lower mortality. In the multivariate
model, age [odds ratio (OR) 1.072, 95% CI
1.011e1.136; p ¼ 0.020], syncope (OR 24,843, 95% CI
3,207e192,431; p ¼ 0.002), hypocalcemia (OR 0.268,
95% CI 0,083e0,862; p ¼ 0.027), not having surgery
(OR 0,123, 95% CI 0,030e0,507; p ¼ 0.004), and SII
(OR 16,886, 95% CI 1,777e160,490; p ¼ 0.014)
remained independent predictors of in-hospital
mortality (Table 2). In the ROC curve analysis, using
a cut point of 2314, the area under the curve (AUC)
for the systemic immune inﬂammation index was
0.641 (95% CI, 0.524e0.757; P ¼ 0.019) (Fig. 1). SII had
33% sensitivity and 91% speciﬁcity in its association
with in-hospital mortality. Besides SII, details of
NLR, PLR sensitivity and speciﬁcity were shown in
Fig. 2 comparatively.
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Table 1. Baseline characteristics and outcomes of the study patients.

Age
Gender (Female)
Hospitalisation time
Comorbidities
_ drug user
IV
DM
CHF
AF
Cardiac device
Dialysis
Symptoms
Syncope
Fever
CVA-TIA
Laboratory variables
Hgb
WBC
Neu
Lymphocyte
Monocyte
Platelet
MPV
CRP
RDW
Urea
Creatinin
Calcium
NLR
PLR
SII
Native valve
Prosthetic material
PAPs
EF
TEE
Aortic vegetation
Mitral vegetation
Tricuspid vegetation
Pulmonary vegetation
Device vegetation
Abscess
Fistula
Psoedoaneurysm
Dehiscence
Veg. size
Aortic
Mitral
Blood culture results
Coa negative staph.
MRCNS
MSCNS
Staph. aureus
MRSA
MSSA
Streptococcus
Entr faecalis
Gram negative
Brucella
Candida

All patients

Patients without
In-hospital mortality
(n ¼ 103)

Patients with
In-hospital mortality
(n ¼ 30)

p

56 (40e66)
31,6 (42)
35 (20,5e47)

53 (40e62)
33,0 (34)
40 (25e47)

66 (52e72)
26,7 (8)
24 (10e42)

0,001
0,511
0,003

3,8 (5)
15,0 (20)
13,5 (8)
11,3 (15)
9,0 (12)
2,3 (3)

2,9 (3)
13,6 (14)
12,6 (13)
9,7 (10)
9,7 (10)
1,9 (2)

6,7 (2)
20,0 (6)
16,7 (5)
16,7 (5)
6,7 (2)
3,3 (1)

0,315
0,275
0,38
0,226
0,463
0,539

7,5 (10)
61,7 (82)
12,0 (16)

3,9 (4)
63,1 (65)
11,7 (12)

20,0 (6)
56,7 (17)
13,3 (4)

0,009
0,523
0,509

10,6 ± 2
10,1 (7,7e13,9)
7,7 (5,2e10,5)
1,6 (1,1e2)
0,77 ± 0,32
246 ± 97
9,5 ± 1,5
67 (31e119)
15,3 ± 2,4
20 (13e30)
0,95 (0,71e1,2)
8,5 ± 0,7
4,8 (2,8e7)
149,7 (104e204)
1103 (679e1865)
61,7 (82)
38,3 (51)
40 (30e50)
60 (50e60)

10,84 ± 2,08
9,8 (7,5e12,4)
7 (5e9,5)
1,6 (1,3e2,2)
0,74 ± 0,3
252 ± 95,5
9,5 ± 1,5
52 (27e108)
15,2 ± 2,6
17 (12e27)
0,93 (0,7e1,18)
8,6 ± 0,6
4,55 (2,73e6,18)
146,9 (103,4e203,2)
1063 (639e1620)
64,1 (66)
35,9 (37)
40 (25e45)
60 (55e60)

10,09 ± 1,88
13,8 (8,4e17,7)
10,5 (6,6e13,5)
1,4 (1e1,7)
0,89 ± 0,38
228 ± 101,7
9,9 ± 1,9
109,5 (48,8e180)
16 ± 2
32 (21e41)
1,11 (0,8e1,6)
8,2 ± 0,77
7,49 (3,63e12,88))
150,3 (109,8e205)
1471 (841e2576)
53,3 (16)
46,7 (14)
45 (32e60)
50 (45e60)

0,079
0,007
0,002
0,064
0,022
0,228
0,25
0,012
0,095
<0,001
0,026
0,002
0,002
0,561
0,019
0,287

42,1 (56)
54,1 (72)
4,5 (6)
0,8 (1)
5,3 (7)
12,0 (16)
3,8 (5)
4,5 (6)
5,3 (7)

43,9 (43)
59,2 (58)
5,1 (5)
1,0 (1)
5,1 (5)
12,2 (12)
3,1 (3)
5,1 (5)
4,1 (4)

50,0 (13)
53,8 (14)
3,8 (1)
0 (0)
7,7 (2)
15,4 (4)
7,7 (2)
3,8 (1)
11,5 (3)

0,577
0,624
0,631
0,79
0,453
0,443
0,281
0,631
0,159

10,4 ± 5,06
9 (6e13)

11,06 ± 5,72
10,5 (5,5e16)

13,4 ± 6,75
12 (8,5e14)

0,187
0,651

23,3 (31)
15,0 (20)
8,3 (11)
9,8 (13)
2,3 (3)
7,5 (10)
8,3(11)
5,3 (7)
4,8 (6)
0,8 (1)
0,8 (1)

21,4 (22)
11,7 (12)
9,7 (10)
7,7 (8)
1,9 (2)
5,8 (6)
8,8 (9)
6,9 (7)
4 (4)
1,0 (1)
0

30 (9)
26,7 (8)
3,3 (1)
16,6 (5)
3,3 (1)
13,3 (4)
6,6 (2)
0
6,6 (2)
0
3,3 (1)

0,018
0,016

0,131

(continued on next page)
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Table 1 (continued )

Surgery
Complication
Heart failure
Renal failure
CVA-TIA
Peripheral embolus
Septic shock

All patients

Patients without
In-hospital mortality
(n ¼ 103)

Patients with
In-hospital mortality
(n ¼ 30)

p

72,2 (96)

78,6 (81)

50,0 (15)

0,002

6,0 (8)
12,0 (16)
4,5 (6)
2,3 (3)
4,5 (6)

2,9
7,8
3,9
1,9
1,0

16,7 (5)
26,7 (8)
6,7 (2)
3,3 (1)
16,7 (5)

0,015
0,01
0,408
0,539
0,002

(3)
(8)
(4)
(2)
(1)

AF: atrial ﬁbrillation; DM: diabetes mellitus; CHD; congenital heart disease; CHF:congestive heart failure; CRP: C-reactive protein;
CVA:cerebrovascular attack; EF: ejection fraction; MRCNS: methicillin resistant coagulase negative stap. ; MSCNS: methicillin sensitive
coagulase negative stap. ; MRSA: methicillin resistant stap. aureus; MSSA: methicillin sensitive stap. aureus ; NLR: neutrophil
lymphocyte ratio; PAPs: pulmonary artery sistolic pressure; PLR: platelet lymphocyte ratio; RDW: red cell distrubition width; SII:systemic immun-inﬂammation ratio; TEE: transesophageal echocardiography; TIA: transient ischemic attack; WBC: white blood cell

Table 2. Signiﬁcant predictors of in-hospital outcomes in univariable and multivariable regression analysis.
Univariate analysis

Age
Syncope
WBC
Neutrophil
Monocyte
CRP
Urea
Creatinin
Calcium
PAPs
EF
Surgery
Heart failure
Renal failure
Septic shock
NLR
SII

Multivariate analysis

Odds ratio

95% C.I.
(Lower-Upper)

p

Odds ratio

95% C.I.
(Lower-Upper)

p

1,048
6,187
1,096
1,116
3,982
1,008
1,048
1,521
0,362
1,031
0,966
0,272
6,667
4,318
20,4
1,136
4,65

1,016e1,083
1,618e23,664
1,020e1,177
1,032e1,206
1,148e13,196
1,002e1,014
1,021e1,077
1,064e2,174
0,186e0,703
1,007e1,057
0,933e1,000
0,115e0,640
1,492e29,787
1,460e12,769
2,281e182,485
1,043e1,238
1,709e12,651

0,004
0,008
0,012
0,006
0,029
0,01
0,001
0,021
0,003
0,013
0,047
0,003
0,013
0,008
0,007
0,003
0,003

1,072
24,843

1,011e1,136
3,207e192,431

0,02
0,002

0,268

0,083e0,862

0,027

0,123

0,030e0,507

0,004

16,886

1,777e160,490

0,014

NLR: neutrophilelymphocyte ratio; PAPs: systolic pulmonary artery pressure; SII: systemic immune-inﬂammation index

To evaluate associations between SII and clinical
outcome, patients were divided into two groups
according to SII cut-off value (<2314 vs. >2314%).
The properties of these subgroups were compared,
as shown in Table 3. In-hospital mortality was more
common in patients with increased SII (Fig. 3).

4. Discussion
In our study, we investigated different variables in IE
patients affecting mortality. We found that age, syncope, hypocalcemia, renal failure, heart failure, septic
shock, high WBC, neutrophil, monocyte, CRP, urea,
creatinine, PAPs, NLR, and SII, were associated with
high in-hospital mortality. Our study exclusively
focused on SII on the effect of mortality in IE patients.
High SII at admission, older age, syncope, hypocalcemia, not going to surgery were independent

predictors for in-hospital mortality in patients with IE.
Among those factors, SII and syncope had the highest
odds ratio for fatal outcome.
The median age of our patients was 58 (43e66)
similarly to reports of developed countries [16,17].
In our study cohort 30 (22%) patients died during
hospital stay. Coagulase negative staphylococci
were the most common pathogen and prosthetic
valve disease were the most frequent predisposing
valve lesion. Staphylococci of invasive procedure
origin replaced streptococci of dental origin in the
last era, probably because of the reduction in the
incidence of RHD [18]. The reported in-hospital
mortality of patients with IE varies from 12% to
30% [18e20] similarly to our results. %61,7 patients had native valve endocarditis. The most
common valvular complication was perforation
(17,3%).
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Fig. 1. The receiver-operating characteristic curve of systemic immuneinﬂammation index (SII) for predicting in-hospital mortality in patients
with infective endocarditis.

Fig. 2. The receiver-operating characteristic curve of SII, NLR and PLR
for predicting in-hospital mortality in patients with infective
endocarditis.

Table 3. Comparision of outcomes according to SII values.
SII cut off: 2314

Low SII
(n ¼ 113)

High SII
(n ¼ 20)

p

Heart failure
Renal failure
CVA-TIA
Intracerebral hemorrhage
Arrhythmia
Septic shock
In-hospital mortality

5,3 (6)
9,7 (11)
4,4 (5)
2,7 (3)
5,3 (6)
3,5 (4)
17,7 (20)

10,0 (2)
25,0 (5)
5,0 (1)
0
10,0 (2)
10,0 (2)
50,0 (10)

0,345
0,067
0,632
0,611
0,345
0,222
0,003

Surgical therapy was performed in 96 patients
(72.2%) after a median time of 17 days from hospital
admission. The most common indication for surgery
was heart failure followed by prediction of peripheral embolism and uncontrolled infection. In our
study surgery was associated with lower in hospital
mortality in patients with surgical indication in
agreement with the studies of Moreira et al. and
Leone et al. [17,21].
In recent years various inﬂammatory markers
have been investigated in IE. Turak et al. retrospectively analyzed 121 patients with IE and hypothesized that increased NLR is associated with
unfavorable in-hospital outcome [22]. Recent evidence suggests that the NLR provides a higher
predictive value than the stand-alone leukocyte
differential; because it can reﬂect more about disease severity than either of the former leukocyte
subgroups [23,24]. Bozbay et al. [25] also investigated the role of NLR in IE and found an independent association between NLR and in-hospital
mortality. In a study by Guray et al., increased RDW
was an independent predictor of mortality [26]. PLR
levels were found signiﬁcantly higher and independently associated with in-hospital mortality in IE
patients by a study of Zencir et al [27]. In another
study, including 155 IE patients; age, syncope, heart
failure, perforation, septic shock, renal failure, high
RDW were associated with high mortality [28].
The primary mechanism responsible for neutrophilia is that stem cells boost neutrophil generation
by the effects of growth factors [29]. In contrast,
lymphocytopenia is caused by redistribution of
lymphocytes to lymphatic organs, increased catecholamine and cortisol levels, and apoptosis [30].
Platelets release numerous inﬂammatory mediators
and play a pivotal role in inﬂammation. The presence of increased platelets promotes inﬂammation,
which in turn triggers a cascade of events resulting
in the release of neutrophils, monocytes and lymphocytes to the vessel wall. Lymphocytes play an
important role in immune surveillance and immune
defense. Increased platelet and decreased lymphocyte levels in the circulation have been reported to
be associated with the poor prognosis in cardiovascular disease [31]. However, although some authors in the ﬁeld of oncology suggest that another
prognostic biomarker, known as SII, is superior to
NLR, no data are available in cardiac patients.
According to a study of Nie et al., SII was an independent prognostic factor for poor prognosis and
correlated with decreased survival in patients with
epithelial ovarian cancer [32]. Guo et al. found that,
higher SII may be associated with tumor angiogenesis, invasion, and metastasis, thus leading to
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Fig. 3. Comparison of systemic immune-inﬂammation index and neutrophil lymphocyte ratio values in survivors and non-survivors.

poor survival in patients with lung cancer and also
showed better prognostic ability than the NLR and
PLR [33].
In a meta-analysis of Zhang et al., which enrolled
24 published articles with 9,626 cases found that
gastrointestinal cancer patients with a high SII value
had a poor prognosis [34].
Therefore, an elevated SII is correlated with poor
survival in cancer patients according to recent
studies. SII prognoses have already been reported
in, colorectal cancer, prostate cancer, pancreatic
cancer, hepatocellular carcinoma, and gastric cancer
[11,35,36]. Given these results, we wanted to investigate SII, a marker that has not been studied in the
ﬁeld of cardiology, in infective endocarditis patients.
The cutoff value for SII in our study was higher
than the other studies with cancer patients which it
predicted mortality. Numerically high value can be
explained by the inclusion of infected patients. In a
study of Guo et al., the optimal cutoff values for the
prediction of survival were 419.6 for the SII in lung
cancer patients [33]. Kim et al., calculated the
optimal cut-off of SII at diagnosis using AUROC
(area 0.696, 95% conﬁdence interval (CI) 0.612,
0.781), and found that 1,573.56 of SII was a strongest
value for poor outcome [14].
The main limitations of our study are its retrospective design and small sample size. In this study,
we focused on the assessment of the relation between inﬂammatory levels especially SII on admission and in-hospital mortality. Being a ﬁrst study
about SII in cardiology ﬁeld, these results that we
have obtained need to be conﬁrmed further in
large-scale studies.

5. Conclusion
Our study is the ﬁrst to conduct research on SII in
the ﬁeld of cardiology. We demonstrated that high
SII levels are independently associated with inhospital mortality. Besides that age, hypocalcemia,

syncope, not going to surgery were
associated with high mortality. The
be easily measured, is a simple,
inexpensive parameter that allows
high-risk IE patients for mortality.

independently
SII, which can
available, and
us to identify
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